UBS Group
SGYPW

UBS Group’s Synergy Pharmaceuticals, Inc. - Warrants SGYPW Stock Holding History

UBS Group’s Portfolio SGYPW Stock Details SGYPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-312
Closed – – 8361
2016
Q3 		$0 Buy
+312
New +$188 ﹤0.01% 8223
2015
Q3 		– Sell
-2,313
Closed -$9K – 8891
2015
Q2 		$9K Buy
+2,313
New +$4.06K ﹤0.01% 7580

UBS Group's SGYPW Position: Q4 2016 in Review

UBS Group sold out of Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) in Q4 2016, closing a stake of 312 shares.

UBS Group first reported a position in SGYPW in Q2 2015 and held it in 2 quarters. The position peaked at $9K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGYPW as of Q4 2016.

  • UBS Group reported no remaining Synergy Pharmaceuticals, Inc. - Warrants position as of Q4 2016 after selling out during the quarter.
  • UBS Group sold 312 Synergy Pharmaceuticals, Inc. - Warrants shares in Q4 2016.
  • UBS Group first reported a position in Synergy Pharmaceuticals, Inc. - Warrants in Q2 2015 and held it in 2 quarters.
  • UBS Group's Synergy Pharmaceuticals, Inc. - Warrants position peaked at $9K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc. - Warrants as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.